1. Home
  2. VHI vs TBPH Comparison

VHI vs TBPH Comparison

Compare VHI & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VHI
  • TBPH
  • Stock Information
  • Founded
  • VHI 1932
  • TBPH 2013
  • Country
  • VHI United States
  • TBPH United States
  • Employees
  • VHI N/A
  • TBPH N/A
  • Industry
  • VHI Major Chemicals
  • TBPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • VHI Industrials
  • TBPH Health Care
  • Exchange
  • VHI Nasdaq
  • TBPH Nasdaq
  • Market Cap
  • VHI 509.6M
  • TBPH 545.0M
  • IPO Year
  • VHI N/A
  • TBPH N/A
  • Fundamental
  • Price
  • VHI $15.44
  • TBPH $11.52
  • Analyst Decision
  • VHI Sell
  • TBPH Strong Buy
  • Analyst Count
  • VHI 1
  • TBPH 5
  • Target Price
  • VHI $12.00
  • TBPH $16.60
  • AVG Volume (30 Days)
  • VHI 9.8K
  • TBPH 188.1K
  • Earning Date
  • VHI 08-07-2025
  • TBPH 08-12-2025
  • Dividend Yield
  • VHI 2.08%
  • TBPH N/A
  • EPS Growth
  • VHI 269.89
  • TBPH N/A
  • EPS
  • VHI 3.44
  • TBPH N/A
  • Revenue
  • VHI $2,109,500,000.00
  • TBPH $65,266,000.00
  • Revenue This Year
  • VHI $22.20
  • TBPH $51.74
  • Revenue Next Year
  • VHI $7.66
  • TBPH N/A
  • P/E Ratio
  • VHI $4.44
  • TBPH N/A
  • Revenue Growth
  • VHI 4.01
  • TBPH 6.11
  • 52 Week Low
  • VHI $14.10
  • TBPH $7.44
  • 52 Week High
  • VHI $41.75
  • TBPH $11.88
  • Technical
  • Relative Strength Index (RSI)
  • VHI 36.01
  • TBPH 60.17
  • Support Level
  • VHI $15.28
  • TBPH $11.05
  • Resistance Level
  • VHI $15.93
  • TBPH $11.40
  • Average True Range (ATR)
  • VHI 0.51
  • TBPH 0.28
  • MACD
  • VHI -0.24
  • TBPH -0.01
  • Stochastic Oscillator
  • VHI 9.52
  • TBPH 82.31

About VHI Valhi Inc.

Valhi Inc is a holding company that provides chemicals, security products, waste management systems, and real estate development and management services through its subsidiaries. It operates its business in three segments, which are Chemicals, Component Products, and Real Estate Management and Development. The company derives maximum revenue from the Chemicals segment, which produces and markets value-added titanium dioxide pigments (TiO2). TiO2 is used to impart whiteness, brightness, opacity, and durability to various products, including paints, plastics, paper, fibers, and ceramics. Geographically, the company generates maximum revenue from the United States and also has a presence in Germany, Canada, Norway, and Belgium.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: